Riskpilot← Back to searchSign inGet full accessSAMSYNSKLINIKKEN ApS
APSActiveCVR 30353935Druemarken 41Traditional, complementary and alternative medicine activities · NACE 8696Est. 2007— employees
Revenue 2025
—
EBITDA margin
—
Equity ratio
72.3%
Financial strength
Net profit 2025
DKK 570K
+34% vs 2024
| Revenue | — | — |
| EBITDA | DKK 0 | — |
| Net profit | DKK 570K | +34% |
| Total assets | DKK 1,9M | +3% |
| Equity | DKK 1,4M | +62% |
| Employees | — | — |
Legal name
SAMSYNSKLINIKKEN ApS
CVR number
30353935
Legal form
Anpartsselskab
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
12. marts 2007
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive konsulentvirksomhed med test og træning af syn og motorik som hovedaktivitet.
Address
Druemarken 41
Phone
+4561278840
Email
lhc@nfp.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36 | 34 | 35 | 36 | 24 | 0 | — | — | — | — | — | 0 | — | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -3 | -1 | -0 | 2 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -3 | -1 | -0 | 2 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net financials | 443 | 419 | -855 | -66 | 44 | 97 | 37 | -21 | 166 | 343 | 145 | -20 | 425 | 568 |
| Profit before tax | 440 | 418 | -855 | -64 | 69 | 97 | 37 | -21 | 166 | 343 | 145 | -20 | 425 | 568 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | 8 | -0 | 36 | 6 | -0 | -20 | -0 | -2 |
| Net profit | 440 | 418 | -855 | -64 | 69 | 97 | 29 | -21 | 129 | 337 | 145 | -0 | 425 | 570 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.521 | 2.968 | 2.096 | 2.123 | 1.774 | 1.819 | 1.800 | 1.756 | 1.834 | 1.924 | 1.853 | 1.794 | 1.859 | 1.913 |
| Equity | 621 | 982 | 127 | 63 | 132 | 163 | 171 | 150 | 279 | 544 | 615 | 520 | 855 | 1.384 |
| Long-term debt | 527 | 590 | 573 | 605 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.373 | 1.396 | 1.396 | 1.456 | 1.642 | 1.655 | 1.621 | 1.607 | 1.555 | 1.380 | 1.239 | 1.274 | 1.004 | 529 |
| Total debt | 1.900 | 1.986 | 1.969 | 2.060 | 1.642 | 1.655 | 1.629 | 1.607 | 1.555 | 1.380 | 1.239 | 1.274 | 1.004 | 529 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20122025
Equity ratio
72.3%
This company
38.2%
Market median
+89% vs market
20122025
Return on equity
41.2%
This company
18.4%
Market median
+124% vs market
20122025
Net profit margin
56973200.0%
This company
8.1%
Market median
+703372740% vs market
20122025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122025
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LF Audit | Audit | 2007 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2007 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SAMSYNSKLINIKKEN ApS (this company)
NORDIC FOOD PARTNERS A/SBoard members of SAMSYNSKLINIKKEN ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Faurum | Audit | 0 companies |